138 related articles for article (PubMed ID: 32100920)
21. Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis.
Georgiadis P; Liampa I; Hebels DG; Krauskopf J; Chatziioannou A; Valavanis I; de Kok TMCM; Kleinjans JCS; Bergdahl IA; Melin B; Spaeth F; Palli D; Vermeulen RCH; Vlaanderen J; Chadeau-Hyam M; Vineis P; Kyrtopoulos SA;
BMC Genomics; 2017 Sep; 18(1):728. PubMed ID: 28903739
[TBL] [Abstract][Full Text] [Related]
22. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
[TBL] [Abstract][Full Text] [Related]
23. microRNA and Chronic Lymphocytic Leukemia.
Giza DE; Calin GA
Adv Exp Med Biol; 2015; 889():23-40. PubMed ID: 26658994
[TBL] [Abstract][Full Text] [Related]
24. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.
Li PP; Feng LL; Chen N; Ge XL; Lv X; Lu K; Ding M; Yuan D; Wang X
Med Oncol; 2015 Feb; 32(2):479. PubMed ID: 25575438
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
Mraz M; Pospisilova S; Malinova K; Slapak I; Mayer J
Leuk Lymphoma; 2009 Mar; 50(3):506-9. PubMed ID: 19347736
[TBL] [Abstract][Full Text] [Related]
26. Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.
Van Roosbroeck K; Bayraktar R; Calin GA
Methods Mol Biol; 2019; 1881():267-276. PubMed ID: 30350212
[TBL] [Abstract][Full Text] [Related]
27. Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia.
Li PP; Lu K; Geng LY; Zhou XX; Li XY; Wang X
Mol Med Rep; 2016 Jun; 13(6):4934-8. PubMed ID: 27082823
[TBL] [Abstract][Full Text] [Related]
28. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
Patz M; Pallasch CP; Wendtner CM
Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
[TBL] [Abstract][Full Text] [Related]
29. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
[TBL] [Abstract][Full Text] [Related]
31. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
32. Evidence for non-functional Dickkopf-1 (DKK-1) signaling in chronic lymphocytic leukemia (CLL).
Filipovich A; Gandhirajan RK; Gehrke I; Poll-Wolbeck SJ; Kreuzer KA
Eur J Haematol; 2010 Oct; 85(4):309-13. PubMed ID: 20618428
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
34. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
Allegra D; Bilan V; Garding A; Döhner H; Stilgenbauer S; Kuchenbauer F; Mertens D; Zucknick M
Leukemia; 2014 Jan; 28(1):98-107. PubMed ID: 23974981
[TBL] [Abstract][Full Text] [Related]
35. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
36. Biological analysis of chronic lymphocytic leukemia: integration of mRNA and microRNA expression profiles.
Dong L; Bi KH; Huang N; Chen CY
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909901
[TBL] [Abstract][Full Text] [Related]
37. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
Rahmani F; Avan A; Hashemy SI; Hassanian SM
J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
[TBL] [Abstract][Full Text] [Related]
38. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Visone R; Veronese A; Balatti V; Croce CM
Oncotarget; 2012 Feb; 3(2):195-202. PubMed ID: 22350310
[TBL] [Abstract][Full Text] [Related]
39.
Rassenti LZ; Balatti V; Ghia EM; Palamarchuk A; Tomasello L; Fadda P; Pekarsky Y; Widhopf GF; Kipps TJ; Croce CM
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10731-10736. PubMed ID: 28923920
[TBL] [Abstract][Full Text] [Related]
40. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
Abbaci A; Talbot H; Saada S; Gachard N; Abraham J; Jaccard A; Bordessoule D; Fauchais AL; Naves T; Jauberteau MO
Oncogene; 2018 Feb; 37(6):756-767. PubMed ID: 29059151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
